Pharmacological targeting EZH2 to modulate chronic graft-versus-host disease

Pharmacological targeting EZH2 to modulate chronic graft-versus-host disease

Bibliographic Details
Main Author:	Ying Wang
Format:	Article
Language:	English
Published:	Wolters Kluwer Health 2022-07-01
Series:	Blood Science
Online Access:	http://journals.lww.com/10.1097/BS9.0000000000000125

Similar Items

Progress in chronic graft-versus-host disease
by: Paul J Martin
Published: (2011-01-01)

Oral Chronic Graft-Versus-Host Disease
by: David Dean, et al.
Published: (2022-05-01)

Targeting the chemokines in acute graft-versus-host disease
by: Ziwei Xu, et al.
Published: (2025-01-01)

Advance in Targeted Immunotherapy for Graft-Versus-Host Disease
by: Lingling Zhang, et al.
Published: (2018-05-01)

Novel Pharmacological Treatment Options of Steroid-Refractory Graft-versus-Host Disease
by: Iuliia Kovalenko, et al.
Published: (2023-01-01)

B-cell involvement in chronic graft-versus-host disease
by: Rick Kapur, et al.
Published: (2008-11-01)

Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
by: Iskra Pusic, et al.
Published: (2019-03-01)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021-08-01)

Extracorporeal photopheresis for the treatment of chronic graft versus host disease
by: Emin Kansu, et al.
Published: (2022-12-01)

Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease
by: Jan Weile, et al.
Published: (2013-05-01)

S240: TARGETING PRMT1 ALLEVIATES CHRONIC GRAFT-VERSUS-HOST DISEASE BY REDUCING T AND B PATHOGENICITY
by: Xiaoyan Zhao, et al.
Published: (2023-08-01)

IAPs protect host target tissues from graft-versus-host disease in mice
by: Tomomi Toubai, et al.
Published: (2017-08-01)

Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium
by: Joseph Pidala, et al.
Published: (2011-10-01)

Elephantiasis nostra verrucosa in sclerodermatous chronic graft-versus-host disease
by: Jamila Mammadova, MD, MA, et al.
Published: (2025-03-01)

B-cell-directed therapy for chronic graft-versus-host disease
by: Caron A. Jacobson, et al.
Published: (2010-11-01)

Complex interactions of cellular players in chronic Graft-versus-Host Disease
by: Laura Marie Gail, et al.
Published: (2023-06-01)

Palatal superficial mucoceles associated with chronic graft-versus-host disease
by: Bilal Al Masri, et al.
Published: (2023-01-01)

Cutaneous chronic graft versus host disease mimicking verruca vulgaris
by: Soumya Jagadeesan, et al.
Published: (2023-01-01)

Treatment of sclerotic chronic graft-versus-host disease with injections of hyaluronidase
by: Tiffany W. Cheng, BS, et al.
Published: (2023-08-01)

A rare presentation of acute on chronic graft versus host disease
by: Surbhi Khurana, et al.
Published: (2022-01-01)

Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease
by: Gilles Fransolet, et al.
Published: (2016-07-01)

Gene expression profile of chronic oral graft-versus-host disease.
by: Giselle Rocha Pinto, et al.
Published: (2022-01-01)

Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease
by: Ahmad Khoder, et al.
Published: (2018-01-01)

Female urethral stricture from chronic graft-versus-host disease
by: James Roy, et al.
Published: (2021-01-01)

Shellfish allergy–induced overlap chronic graft-versus-host disease
by: Hayley Anne Braun, MD, MPH, et al.
Published: (2021-11-01)

Disease severity in chronic graft-versus-host disease: doctors’ gut feeling versus biostatistics?
by: Gerard Socié
Published: (2014-10-01)

Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
by: Kudakwashe Mhandire, et al.
Published: (2021-10-01)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
by: Haruka Shinohara, et al.
Published: (2022-12-01)

Acute graft versus host disease
by: Vogelsang Georgia B, et al.
Published: (2007-09-01)

NOTCH and Graft-Versus-Host Disease
by: Mauro Di Ianni, et al.
Published: (2018-08-01)

Graft-versus-host diseases characterized by effusion: A case of steroid-refractory graft-versus-host disease
by: Osamu Imataki, et al.
Published: (2018-06-01)

Reactivated chronic graft-versus-host disease following SARS-CoV-2 infection
by: Brian Florenzo, BS, BA, et al.
Published: (2022-08-01)

APRIL levels are associated with disease activity in human chronic graft-versus-host disease
by: François Chasset, et al.
Published: (2016-07-01)

Organ-specific management and supportive care in chronic graft-versus-host disease.
by: Dignan, F, et al.
Published: (2012)

IL-17 Genetic and Immunophenotypic Evaluation in Chronic Graft-versus-Host Disease
by: Renata Gonçalves Resende, et al.
Published: (2014-01-01)

Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease
by: Takanobu Morishita, et al.
Published: (2025-02-01)

Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease
by: Eleni Gavriilaki, et al.
Published: (2024-09-01)

Evaluation of prognostic factors among patients with chronic graft-versus-host disease
by: Jose A. Pérez-Simón, et al.
Published: (2012-08-01)

Ikaros expression is associated with an increased risk of chronic graft-versus-host disease
by: A. D. Pereira, et al.
Published: (2023-05-01)

UPDATES ON MUSCULOSKELETAL ISSUES AND REHABILITATION INTERVENTIONS IN CHRONIC GRAFT-VERSUS-HOST DISEASE
by: Monica Pinto, et al.
Published: (2023-07-01)